Phase I Study of Two Schedules of Oral S-1 in Combination with Fixed Doses of Oxaliplatin and Bevacizumab in Patients with Advanced Solid Tumors

Publisher： Karger

E-ISSN： 1423-0232|81|2|65-72

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.2, 2011-09, pp. : 65-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination with Oral Vinorelbine in Patients with Advanced Solid Malignancies

By  

Oncology Research and Treatment, Vol. 36, Iss. 1-2, 2013-01 ,pp. : 40-45

Karger

Access to resources Recommend Favorite

Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors

By  

Oncology, Vol. 91, Iss. 5, 2016-09 ,pp. : 251-260

Karger

Access to resources Recommend Favorite

A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 421-427

Karger

Access to resources Recommend Favorite

Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 253-259

Karger

Access to resources Recommend Favorite

A Dose-Escalation Study of Oxaliplatin and Vinorelbine in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 213-218

Karger

Access to resources Recommend Favorite